INHIBITORY EFFECT OF YANGKYUK-SANHWA-TANG ON INFLAMMATORY CYTOKINE PRODUCTION IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM THE CEREBRAL INFARCTION PATIENTS

REFERENCES

• Ali C., Nicole O., Docagne F., Lesne S., Mackenzie E. T., Nouvelot A., Buisson A., Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. Journal of Cerebral Blood Flow and Metabolism 2000; 20: 956–966
   PubMed Web of Science ®Google Scholar
• Barone F. C., Arvin B., White R. F., Miller A., Webb C. L., Willette R. N., Lysko P.G., Feuerstein G. Z. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997; 28: 1233–1244
   PubMed Web of Science ®Google Scholar
• Ben Trivedi A., Kitabatake N., Doi E. Toxicity of dimethyl sulfoxide as a solvent in bioassay system with HeLa cells evaluated colorimetrically with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide. Agricultural and Biological Chemistry 1990; 54: 2961–2966
   PubMedGoogle Scholar
• Boutin H., Kimber I., Rothwell N. J., Pinteaux E. The expanding interleukin-1 family and its receptors: Do alternative IL-1 receptor/signaling pathways exist in the brain?. Molecular Neurobiology 2003; 27: 239–248
   PubMed Web of Science ®Google Scholar
• Frei K., Leist T. P., Meager A., Gallo P., Leppert D., Zinkernagel R. M., Fontana A. Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. Journal of Experimental Medicine 1988; 168: 449–453
   PubMed Web of Science ®Google Scholar
• Gallo P., Frei K., Rordorf C., Lazdins J., Tavolato B., Fontana A. Human immunodeficiency virus type 1 (HIV-1) infection of the central nervous system: An evaluation of cytokines in cerebrospinal fluid. Journal of Neuroimmunology 1989; 23: 109–116
   PubMed Web of Science ®Google Scholar
• Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proceedings of the National Academy of Sciences of the United States of America. 1987; 7251–7255, 84
   Google Scholar
• Grau A. J., Reis A., Buggle F., Al-Khalaf A., Werle E., Valois N., Bertram M., Becher H., Grond-Ginsbach C. Monocyte function and plasma levels of interleukin-8 in acute ischemic stroke. Journal of the Neurological Sciences 2001; 192: 41–47
   Google Scholar
• Härtl R., Schürer L., Schmid-Schonbein G. W., del Zoppo G. J. Experimental antileukocyte interventions in cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 1996; 16: 1108–1119
   PubMed Web of Science ®Google Scholar
• Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., Nakajima K., Pyun K. H., Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proceedings of the National Academy of Sciences of the United States of America. 1985; 5490–5494, 82
   Google Scholar
• Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., Kashiwamura S., Nakajima K., Koyama K., Iwamatsu A., Tsunasawa S., Sakiyama F., Matsui H., Takahara Y., Taniguchi T., Kishimoto T. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986; 324: 73–76
   PubMed Web of Science ®Google Scholar
• Houssiau F. A., Bukasa K., Sindic C. J., Van Damme J., Van Snick J. Elevated levels of the 26 K human hybridoma growth factor (interleukin 6) in cerebrospinal fluid of patients with acute infection of the central nervous system. Clinical and Experimental Immunology 1988; 71: 320–323
   PubMed Web of Science ®Google Scholar
• Jeong H. J., Hong S. H., Park H. J., Kweon D. Y., Lee S. W., Lee J. D., Kim K. S., Cho K. H., Kim H. S., Kim K. Y., Kim H. M. Yangkyuk-Sanhwa-Tang induces changes in serum cytokines and improves outcome in focal stroke patients. Vascular Pharmacology 2002; 39: 63–68
   PubMed Web of Science ®Google Scholar
• Jeong H. J., Na H. J., Hong S. H., Kim H. M. Inhibition of the stem cell factor-induced migration of mast cells by dexamethasone. Endocrinology 2003; 144: 4080–4086
   PubMed Web of Science ®Google Scholar
• Kawamata T., Dietrich W. D., Schallert T., Gotts J. E., Cocke R. R., Benowitz L. I., Finklestein S. P. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proceedings of the National Academy of Sciences of the United States of America. 1997; 8179–8184, 94
   Google Scholar
• Kochanek P. M., Hallenbeck J. M. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23: 1367–1379
   PubMed Web of Science ®Google Scholar
• Leppert D., Frei K., Gallo P., Yasargil M. G., Hess K., Baumgartner G., Fontana A. Brain tumors: Detection of B-cell stimulatory factor-2/interleukin-6 in the absence of oligoclonal bands of immunoglobulins. Journal of Neuroimmunology 1989; 24: 259–264
   PubMedGoogle Scholar
• Masihi K. N., Madaj K., Hintelmann H., Gast G., Kaneko Y. Down-regulation of tumor necrosis factor-alpha, moderate reduction of interleukin-1beta, but not interleukin-6 or interleukin-10, by glucan immunomodulators curdlan sulfate and lentinan. International Journal of Immunopharmacology 1997; 19: 463–468
   PubMed Web of Science ®Google Scholar
• Matsumoto T., Ikeda K., Mukaida N., Harada A., Matsumoto Y., Yamashita J., Matsushima K. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Laboratory Investigation 1997; 77: 119–125
   PubMed Web of Science ®Google Scholar
• Ohno N., Morrison D. C. Lipopolysaccharide interactions with lysozyme differentially affect lipopolysaccharide immunostimulatory activity. European Journal of Biochemistry 1989; 186: 629–636
   PubMedGoogle Scholar
• Tarkowski E., Rosengren L., Blomstrand C., Wikkelso C., Jensen C., Ekholm S. Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clinical and Experimental Immunology 1997; 110: 492–499
   PubMed Web of Science ®Google Scholar
• Touzani O., Boutin H., Chuquet J., Rothwell N. Potential mechanisms of interleukin-1 involvement in cerebral ischemia. Journal of Neuroimmunology 1999; 100: 203–215
   PubMed Web of Science ®Google Scholar
• Tsuzuki H., Tani T., Ueyama H., Kodama M. Lipopolysaccharide: Neutralization by polymyxin B shuts down the signaling pathway of nuclear factor kappaB in peripheral blood mononuclear cells, even during activation. The Journal of Surgical Research 2001; 100: 127–134
   PubMed Web of Science ®Google Scholar
• Um J. Y., Moon K. S., Lee K. M., Kim H. M. Interleukin-1 gene cluster polymorphisms in cerebral infarction. Cytokine 2003; 23: 41–46
   Google Scholar
• Wiessner C., Gehrmann J., Lindholm D., Topper R., Kreutzberg G. W., Hossmann K. A. Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia. Acta Neuropathologica (Berl) 1993; 86: 439–446
   PubMed Web of Science ®Google Scholar
• Yang G. Y., Gon C., Qin Z., Ye W., Mao Y., Bertz A. L. Inhibition of TNFalpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport 1998; 9: 2131–2134
   PubMed Web of Science ®Google Scholar